期刊文献+

生物制剂治疗炎症性肠病的应用原则和评价 被引量:2

下载PDF
导出
作者 刘梅 刘南植
出处 《内科急危重症杂志》 2010年第5期234-236,共3页 Journal of Critical Care In Internal Medicine
  • 相关文献

参考文献2

二级参考文献15

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.
  • 4欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84.
  • 5Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413.
  • 6Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753.
  • 7Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75.
  • 8Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643.
  • 9Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut, 2006, 55 Suppl 1:i1- i15.
  • 10Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut, 2004, 53 Suppl 5: Ⅴ1-Ⅴ16.

共引文献1121

同被引文献22

  • 1夏冰,程虹.溃疡性结肠炎的生物治疗[J].临床消化病杂志,2007,19(1):16-19. 被引量:21
  • 2Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel dis ease. Gastroenterology, 2007, 133:1670.
  • 3Van Staa TP, Leufkens HG, Abenhaim L, et al. Oral cortico steroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford), 2000, 39: 1383.
  • 4Lafage-Proust MH, Boudignon B, Thomas T. Glucocorticoid-in duced osteoporosis: pathophysiological data and recent treat- ments. Joint Bone Spine, 2003, 70:109.
  • 5Humphrey EL, Williams JH, Davie MW, et al. Effects of disso- ciated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone, 2006, 38:652.
  • 6Bischoff SC, Herrmann A, Goke M, et al. Altered bone metab- olism in inflammatory bowel disease. Am J Gastroenterol, 1997, 92:1157.
  • 7Leonard MB. Glucocorticoid induced osteoporosis in children: impact of the underlying disease. Pediatrics, 2007, 119:S166.
  • 8Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnor- malities, mechanisms and interventions. Rheumatology (Ox ford), 2004, 43: 1219.
  • 9Szulc P, Meunier PJ. Is vitamin K deficiency a risk factor for os- teoporosis in Crohn's disease? Lancet, 2001, 357 : 1995.
  • 10Grossman JM, Gordon R. Ranganath VK, et al. American col lege of rheumatology 2010 recomn,endations for the prevention and treatment of glucocorticoid induced osteoporosis. Arthritis Care & Research, 2010, 62:1515.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部